These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38218896)

  • 21. Villin expression in human tumors: a tissue microarray study on 14,398 tumors.
    Dum D; Lennartz M; Menz A; Kluth M; Hube-Magg C; Weidemann S; Fraune C; Luebke AM; Hornsteiner L; Bernreuther C; Simon R; Clauditz TS; Sauter G; Uhlig R; Hinsch A; Kind S; Jacobsen F; Möller K; Wilczak W; Steurer S; Minner S; Burandt E; Marx AH; Krech T; Lebok P
    Expert Rev Mol Diagn; 2022 Jun; 22(6):665-675. PubMed ID: 35866621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synaptophysin and chromogranin A expression analysis in human tumors.
    Uhlig R; Dum D; Gorbokon N; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Sauter G; Wilczak W; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Simon R; Minner S
    Mol Cell Endocrinol; 2022 Sep; 555():111726. PubMed ID: 35921917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
    Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
    Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer.
    Pin E; Henjes F; Hong MG; Wiklund F; Magnusson P; Bjartell A; Uhlén M; Nilsson P; Schwenk JM
    J Proteome Res; 2017 Jan; 16(1):204-216. PubMed ID: 27700103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors.
    Dwertmann Rico S; Schliesser SJA; Gorbokon N; Dum D; Menz A; Büscheck F; Hinsch A; Lennartz M; von Bargen C; Bawahab AA; Luebke AM; Hube-Magg C; Fraune C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Hoeflmayer D; Krech T; Bernreuther C
    Pathol Int; 2023 Jul; 73(7):281-296. PubMed ID: 37057870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors.
    Kind S; Castillo CP; Schlichter R; Gorbokon N; Lennartz M; Hornsteiner LS; Dwertmann Rico S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Hinsch A; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Wilczak W; Sauter G; Menz A; Jacobsen F
    BMC Cancer; 2024 Jul; 24(1):794. PubMed ID: 38961454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence.
    Pust A; Kylies D; Hube-Magg C; Kluth M; Minner S; Koop C; Grob T; Graefen M; Salomon G; Tsourlakis MC; Izbicki J; Wittmer C; Huland H; Simon R; Wilczak W; Sauter G; Steurer S; Krech T; Schlomm T; Melling N
    Hum Pathol; 2016 Feb; 48():102-10. PubMed ID: 26614400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate.
    Friedman RS; Spies AG; Kalos M
    Eur J Immunol; 2004 Apr; 34(4):1091-101. PubMed ID: 15048720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GATA3 Positivity in Benign Radiated Prostate Glands: A Potential Diagnostic Pitfall.
    Wobker SE; Khararjian A; Epstein JI
    Am J Surg Pathol; 2017 Apr; 41(4):557-563. PubMed ID: 28291125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of NKX3.1, P501S, Prostate-Specific Antigen, and Steroidogenic Factor 1 to Distinguish Malignant Leydig Cell Tumor From Metastatic Prostatic Adenocarcinoma to the Testis.
    Erak E; Ulbright TM; Epstein J
    Arch Pathol Lab Med; 2023 Dec; 147(12):1458-1460. PubMed ID: 36881770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative multi-gene expression profiling of primary prostate cancer.
    Schmidt U; Fuessel S; Koch R; Baretton GB; Lohse A; Tomasetti S; Unversucht S; Froehner M; Wirth MP; Meye A
    Prostate; 2006 Oct; 66(14):1521-34. PubMed ID: 16921506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein.
    Kiessling A; Stevanovic S; Füssel S; Weigle B; Rieger MA; Temme A; Rieber EP; Schmitz M
    Br J Cancer; 2004 Mar; 90(5):1034-40. PubMed ID: 14997204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells.
    Musiyenko A; Bitko V; Barik S
    J Mol Med (Berl); 2008 Mar; 86(3):313-22. PubMed ID: 18193184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.
    Perner S; Rupp NJ; Braun M; Rubin MA; Moch H; Dietel M; Wernert N; Jung K; Stephan C; Kristiansen G
    Int J Cancer; 2013 Feb; 132(4):807-12. PubMed ID: 22821757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.
    Gilani S; Guo CC; Li-Ning EM; Pettaway C; Troncoso P
    Hum Pathol; 2017 Jun; 64():186-190. PubMed ID: 28159676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples.
    Rico SD; Mahnken M; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Möller-Koop C; Fraune C; Möller K; Menz A; Bernreuther C; Jacobsen F; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Marx AH
    Technol Cancer Res Treat; 2021; 20():15330338211043328. PubMed ID: 34547930
    [No Abstract]   [Full Text] [Related]  

  • 38. Aberrant GATA3 Staining in Prostatic Adenocarcinoma: A Potential Diagnostic Pitfall.
    McDonald TM; Epstein JI
    Am J Surg Pathol; 2021 Mar; 45(3):341-346. PubMed ID: 32769430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
    Reiswich V; Könemann S; Lennartz M; Höflmayer D; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Kind S; Jacobsen F; Steurer S; Minner S; Büscheck F; Burandt E; Marx AH; Lebok P; Krech T
    Pathol Res Pract; 2022 Sep; 237():154028. PubMed ID: 35872365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive analysis of PAX8 expression in human epithelial tumors.
    Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS
    Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.